Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens
1996

Cortisol Patterns in Breast and Ovarian Cancer Patients

Sample size: 33 publication Evidence: moderate

Author Information

Author(s): Y Touitou, A Bogdan, F Levi, M Benavides, A Auzeby

Primary Institution: Department of Biochemistry, Faculte de Medecine Pitie-Salpetriere, Paris, France; Laboratoire Rythmes Biologiques et Chronotherapeutique, Hôpital Paul Brousse, Villejuif, France.

Hypothesis

Are the circadian patterns of serum cortisol and tumor marker antigens altered in breast and ovarian cancer patients?

Conclusion

The study found that a significant number of breast and ovarian cancer patients exhibited altered circadian patterns of serum cortisol.

Supporting Evidence

  • 8 out of 13 breast cancer patients had altered cortisol patterns.
  • 15 out of 20 ovarian cancer patients exhibited abnormal cortisol profiles.
  • Variations of tumor marker antigens were observed to be as large as 70% within 24 hours.

Takeaway

Doctors looked at how the hormone cortisol changes throughout the day in cancer patients and found that many had unusual patterns.

Methodology

Blood samples were taken every 4 hours over 24 hours to measure serum cortisol and tumor marker antigens.

Limitations

The study only included a small number of patients and did not establish a direct relationship between cortisol patterns and tumor markers.

Participant Demographics

33 cancer patients (13 breast cancer, 20 ovarian cancer) with a mean age of 52 years for breast cancer and 55 years for ovarian cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication